Zobrazeno 1 - 10
of 654
pro vyhledávání: '"S, Rangan"'
Autor:
Deepak Nandkishore Sharma, Vamsi Krishna Yerramneni, Thirumal Yerragunta, Govind B Gaikwad, Vasundhara S Rangan, Sasank Akurati
Publikováno v:
Journal of Craniovertebral Junction and Spine, Vol 15, Iss 1, Pp 37-44 (2024)
Objective: Hirayama disease is a rare cause of cervical myelopathy predominantly affecting young individuals. The disease is classically characterized by muscle atrophy in the distal upper limbs. While various etiopathogenesis such as dural sac dyspl
Externí odkaz:
https://doaj.org/article/39f3f2eced434cd8b7a4d863c0eb5968
Autor:
Jennifer H. Pham, Gretchen A. Johnson, Rajiv S. Rangan, Charles E. Amankwa, Suchismita Acharya, Dorota L. Stankowska
Publikováno v:
Cells, Vol 11, Iss 23, p 3741 (2022)
The mechanisms underlying the neuroprotective effects of the hybrid antioxidant-nitric oxide donating compound SA-2 in retinal ganglion cell (RGC) degeneration models were evaluated. The in vitro trophic factor (TF) deprivation model in primary rat R
Externí odkaz:
https://doaj.org/article/9e4d125467fe4f51889df93431d7ed27
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Pina M. Cardarelli, Julien Sage, Kwon-Sik Park, Sandra Cristea, Shrikant Deshpande, Vangipuram S. Rangan, Xi-Tao Wang, Huadong Sun, Heidi LeBlanc, Debbie Strachan, Miho Oyasu, Bing Chen, Chin Pan, Daniel Menezes, Paul Ponath
Purpose: The ganglioside fucosyl-GM1 (FucGM1) is a tumor-associated antigen expressed in a large percentage of human small cell lung cancer (SCLC) tumors, but absent in most normal adult tissues, making it a promising target in immuno-oncology. This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cd6c0ae145f942e06163a0de2e8b4d0
https://doi.org/10.1158/1078-0432.c.6529013
https://doi.org/10.1158/1078-0432.c.6529013
Autor:
Pina M. Cardarelli, Julien Sage, Kwon-Sik Park, Sandra Cristea, Shrikant Deshpande, Vangipuram S. Rangan, Xi-Tao Wang, Huadong Sun, Heidi LeBlanc, Debbie Strachan, Miho Oyasu, Bing Chen, Chin Pan, Daniel Menezes, Paul Ponath
4 suppl figures on tumor models
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d253c03d289cadd2f8077bb43c5e3311
https://doi.org/10.1158/1078-0432.22475165.v1
https://doi.org/10.1158/1078-0432.22475165.v1
Autor:
Pina M. Cardarelli, Julien Sage, Kwon-Sik Park, Sandra Cristea, Shrikant Deshpande, Vangipuram S. Rangan, Xi-Tao Wang, Huadong Sun, Heidi LeBlanc, Debbie Strachan, Miho Oyasu, Bing Chen, Chin Pan, Daniel Menezes, Paul Ponath
4 suppl tables on FucGM1 expression in lung cancer, binding, and mouse PK
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d62ed2c1d2fa823410527d226168d82
https://doi.org/10.1158/1078-0432.22475162
https://doi.org/10.1158/1078-0432.22475162
Autor:
J. Piret, H.G. Schulze, S. Rangan, M. Vardaki, K.N. MacDonald, D. Iworima, M. Levings, T.J. Kieffer, M.W. Blades, R.F. Turner
Publikováno v:
Cytotherapy. 25:S199
Autor:
Christine Bee, Olafur S. Gudmundsson, Guodong Chen, Amy Jhatakia, Andy X. Deng, Natalie Bezman, Richard Y.-C. Huang, Yun Wang, Vangipuram S. Rangan, Shrikant Deshpande
Publikováno v:
Journal of the American Society for Mass Spectrometry. 32:1567-1574
NK group 2 member A (NKG2A), an immune checkpoint inhibitor, is an emerging therapeutic target in immuno-oncology. NKG2A forms a heterodimer with CD94 on the cell surface of NK and a subset of T cells and recognizes the nonclassical human leukocyte a
Autor:
Manjul Tripathi, Prasant Maskara, Antonio A.F. De Salles, Narendra Kumar, Sandeep Mohindra, Vasundhara S. Rangan
Publikováno v:
World Neurosurgery. 145:323-333
Background Microsurgical callosotomy is a procedure still under debate and to best a palliative treatment for drug-resistant epilepsy. Unlike microsurgery, radiosurgical callosotomy is an underpracticed treatment option, with no definite account of i
Autor:
Kavitha Vemuri, Sanjeev Gangwar, Vangipuram S. Rangan, Mary Huber, Tom Kempe, Janette Sung, Colin Chong, Jennifer Juliano, Alice Stevens, Severino Cuison, Shrikant Deshpande, Meghan Greenbaum, Heng Cheng, Chetana Rao-Naik, Chin Pan, Qiang Cong, Jerry Jiang, Gregory D. Vite, Dan Dervin, David Passmore, Andrea L. Tatum, Eilene Kwok, Pina M. Cardarelli
Publikováno v:
Bioconjugate Chemistry. 31:2350-2361
Antibody-drug conjugates (ADCs) use antibodies to deliver cytotoxic payloads directly into tumor cells via specifically binding to the target cell surface antigens. ADCs can enhance the anti-tumor effects of antibodies, and increase the delivery of c